Timing last evening meals is critical for people with prediabetes, study suggests

New research shows that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged 10–17 years whose diabetes and weight are inadequately controlled with an existing treatment regimen of metformin, insulin, or both.

The global type 1 diabetes (T1D) burden continues to increase rapidly, driven by rising cases, aging populations, improved diagnosis and falling death rates, according to the results of a new modeling study presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), Vienna (15–19 Sept).

New research (the Ver-A-T1D trial) presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15–19 September) shows that slow-release (SR) verapamil (360mg daily) could have a potential effect on beta-cell function in adults with newly diagnosed type 1 diabetes.

In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, could safely preserve the body's own insulin production and slow the progression of type 1 diabetes (T1D) in people recently diagnosed with the condition.

New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published simultaneously in The Lancet shows that a much lower dose than previously thought of the old immunomodulatory drug anti-thymocyte globulin (ATG) is safe and effective in preventing progression of type 1 diabetes (T1D) in young people.

Cervical cancer is the fourth-most common cancer among women globally, according to the World Health Organization. It accounted for 660,000 new cases and 350,000 deaths in 2022.

The production and use of over 400 million tons of plastic each year has polluted beaches, rivers, and even the deepest parts of the ocean, reaching depths of up to 11,000 meters. In addition to visible environmental impacts, plastic contributes to climate change. It is estimated that plastic production generates 1.8 billion tons of greenhouse gases per year. Scientific evidence also suggests that using plastic materials in everyday life has impacted human health.

A new study from the University of Oklahoma reveals how a little-understood protein, CD82, contributes to blood vessel leakage, a process that initiates inflammation but becomes dangerous when it occurs during severe inflammatory diseases such as sepsis, acute respiratory distress syndrome and COVID-19.

Researchers led by Rice University's Yong Lin Kong have developed a soft but strong metamaterial that can be controlled remotely to rapidly transform its size and shape.

Patients in specialized psychiatric care face a variety of social risks that are intertwined, according to a new study from the University of Eastern Finland published in Nordic Social Work Research. Social risks tend to accumulate among the most vulnerable segments of the population. They include, for example, financial difficulties, housing challenges and violence.

The brain is famously plastic: Neurons' ability to change their behavior in response to new stimuli is what makes learning possible. And even neurons' response to the same stimuli changes over time—a phenomenon known as representational drift. Yet our day-to-day perception of the world is relatively stable. How so?

Rakesh Jain, Ph.D., director of the Edwin Steele Laboratories for Tumor Biology in the Department of Radiation Oncology at Massachusetts General Hospital and Andrew Werk Professor of Radiation Oncology at Harvard Medical School, is senior and corresponding author of a new paper in Proceedings of the National Academy of Sciences, "Wnt Inhibition Alleviates Resistance to Anti-PD1 Therapy and Improves Anti-Tumor Immunity in Glioblastoma."

A new study from UC Davis Health researchers reveals a promising new way to treat various bone loss conditions, including age-related osteoporosis.

Epilepsy patients who experience breathing interruptions after a seizure may be at a higher risk of sudden unexpected death later in life, according to researchers at UTHealth Houston.

Cerebral malaria kills 1 out of 5 children that suffer from it, and causes long-term disabilities in half of the survivors. Malaria is caused by the parasite Plasmodium falciparum, which reproduces in our red blood cells and then breaks out of them to continue infecting new cells. Once the parasite makes it to the blood–brain barrier (BBB), a structure that protects the brain from harmful substances, it is able to damage it, causing severe complications.

Spinal cord injury is one of the leading causes of long-term disability worldwide, often impacting young people who face a lifetime of physical and neurological challenges ahead. A new study questions a widely accepted treatment strategy in the critical first days after injury, findings that could reshape ICU protocols and improve patient outcomes.

A new study from researchers at the Fairbanks School of Public Health examined how accurate health care settings are at measuring food insecurity, housing instability, financial strain, transportation barriers and legal issues.

Indiana University School of Medicine scientists have identified a new way to weaken pancreatic cancer's defenses by targeting two key proteins that help the deadly disease resist treatment. The study, recently published in Redox Biology, revealed that a drug combination blocking the proteins together may offer a more effective strategy against pancreatic cancer and potentially other aggressive cancers.